Eversana expands Asian footprint with four new offices

By Vassia Barba

- Last updated on GMT

(Image: Getty/Andrey Tolkachev)
(Image: Getty/Andrey Tolkachev)

Related tags Eversana Commercialization Service provider Asia Asia pacific

Eversana looks to enhance its service in Asia and meet ‘increased’ demand with new offices in Singapore, Mumbai, Shanghai, and Tokyo.

The company, which develops software services for drug commercialization, announced the opening of its offices in Singapore and Mumbai, with the concurrent appointment of a regional leadership team which will be based in Singapore.

Additionally, Eversana announced plans to open offices in Shanghai and Tokyo by the end of 2019, along with an intention to invest ‘significant’ capital resources to build its regional footprint.

According to the company, this move answers an increased need for global solution capabilities for companies headquartered in Asia, as well as US and European headquartered companies looking to bring solutions to the Asian markets.

Jim Lang, CEO of Eversana, commented in a statement that China and Japan are now the second and third largest life sciences markets and “are widely regarded as vital contributors to the future of precision medicine.”

The company already has offices in 25 locations across North America, Europe and Asia, and employs more than 2,000 people.

Eversana also recently announced an agreement​ to adopt Cryoport’s cold chain logistics services for regenerative medicines.

Related news

Show more

Related products

show more

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Content provided by Elligo Health Research® | 13-Apr-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Content provided by Formedix | 10-Mar-2023 | White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

Related suppliers

Follow us


View more